ABCL vs REGN: Which Stock is Better?
Side-by-side comparison of Abcellera Biologics Inc and Regeneron Pharmaceuticals Inc in 2026
ABCL
Abcellera Biologics Inc
—
REGN
Regeneron Pharmaceuticals Inc
$654.27
Key Metrics Comparison
| Metric | ABCL | REGN | Winner |
|---|---|---|---|
| Market Cap | $1.12B | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze ABCL
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABCL or REGN a better investment?
Comparing ABCL and REGN: Abcellera Biologics Inc has a market cap of $1.12B while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABCL and REGN?
ABCL (Abcellera Biologics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABCL or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ABCL or REGN?
Both ABCL and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: ABCL or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: ABCL or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $1.12B for ABCL.
Should I buy ABCL or REGN in 2026?
Both ABCL and REGN have investment merit. ABCL trades at $N/A while REGN trades at $654.27. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABCL and REGN stock?
Key differences: Market Cap ($1.12B vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy ABCL or REGN in 2026?
The choice between ABCL and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ABCL and REGN?
ABCL (Abcellera Biologics Inc) has a market cap of $1.12B, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.